Skip to content

Diagnostic Performance of Serum Endocan in Diagnosis of Organ Failure in Hospitalized Cirrhotic Patients

Diagnostic Performance of Serum Endocan in Diagnosis of Organ Failure in Hospitalized Cirrhotic Patients

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
TCTR
Registry ID
TCTR20220415001
Enrollment
115
Registered
2022-04-15
Start date
2021-06-18
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Organ failures in hospitalized cirrhotic patients ESM1 protein, human Procalcitonin Interleukin-6 Acute-on-chronic liver failure Liver Cirrhosis

Interventions

Cirrhotic patients who are admitted to the hospital within 24 hours and don&#039
t have organ failures at recruitment,Cirrhotic patients who are admitted to the hospital within 24 hours and have organ failures at recruitment
Diagnostic,Diagnostic
Hospitalized cirrhotic patients without organ failures,Hospitalized cirrhotic patients with organ failures

Sponsors

Liver Research Unit, Chulalongkorn University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Hospitalized cirrhotic patients

Exclusion criteria

Exclusion criteria: 1. Active cancer within 2 years prior to participation 2. Myocardial infarction with 50% stenosis in one of major vessels 3. Chronic kidney disease stage V 4. Chronic obstructive pulmonary disease 5. Pervious participation in this study and had readmission

Design outcomes

Primary

MeasureTime frame
Organ failure at recruitment ACLF criteria by EASL guideline

Secondary

MeasureTime frame
Organ failure within 90 days after recruitment ACLF criteria by EASL guideline,Mortality within 90 days after recruitment Death

Countries

Thailand

Contacts

Public ContactKessarin Thanapirom

Staff

tkessarin@hotmail.com0830685211

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026